Product Information
CLORAZEPATE 3.75 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.6298 per EA under NDC 70954015930. Its NADAC has been published 138 times since Nov 8, 2023.
Strength
3.75 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954015930
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLORAZEPATE DIPOTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA213730On Market Since
6/16/2022
Pharmacological Classes
Price Statistics
The NADAC for CLORAZEPATE 3.75 MG TABLET has been published 138 times since Nov 8, 2023, and over the history we have for it it has declined 10.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6298 per EA |
|---|---|
| All-time high | $1.0264 (Nov 13, 2024) |
| All-time low | $0.6005 (Jan 17, 2024) |
| 52-week high | $0.8878 |
| 52-week low | $0.6042 |
| Median price | $0.7975 |
| Average price | $0.7740 |
| Largest weekly change | +48.9% (Sep 18, 2024) |
| Weeks tracked | 138 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLORAZEPATE 3.75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLORAZEPATE 3.75 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.6298 per EA (NDC 70954015930), effective Jun 24, 2026.
How has the price of CLORAZEPATE 3.75 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLORAZEPATE 3.75 MG TABLET has declined 10.2%. It has been tracked across 138 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for CLORAZEPATE 3.75 MG TABLET?
Since Nov 8, 2023, the NADAC for CLORAZEPATE 3.75 MG TABLET has ranged from a low of $0.6005 (Jan 17, 2024) to a high of $1.0264 (Nov 13, 2024), with a median of $0.7975 per EA.
Are there cheaper alternatives to CLORAZEPATE 3.75 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as CLORAZEPATE 3.75 MG TABLET, but none are currently priced below it.
Who manufactures CLORAZEPATE 3.75 MG TABLET?
CLORAZEPATE 3.75 MG TABLET (NDC 70954015930) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification